St John's DermAcademy Podcast: Recent Episodes
St John's DermAcademy
Our Podcasts are delivered to you by clinicians and academics at St John’s Institute of Dermatology and invited speakers. Our aim is to update you and share practical tips on how experts in their field diagnose and treat common dermatological conditions in our short episodes that you can easily listen to whilst on the go. Our podcasts are targeted at healthcare professionals including dermatology consultants, dermatology trainees, GPs and specialist nurses. Disclaimer: The information on our podcasts is based on the latest evidence and expert opinion at the time of recording. The information is for general purposes only and we cannot offer advice for specific patients. Equally, this information is geared towards healthcare professionals. Any member of the public or patients listening should not use this as advice to treat their own condition or others and should consult their own physician for any medical they may have.
In this episode our host Dr Sarah Drummond speaks with Professor Catherine Smith and Dr Andrew Pink about eczema therapeutics:
• The use of JAK inhibitors licensed for use in managing eczema including their mechanism of action, monitoring requirements and potential side effects.
• Newer agents currently under investigation.
• The BEACON trial
Recorded: 19 March 2024
For more information, visit: www.stjohnsdermacademy.com/podcasts
Disclaimer: The information on our podcasts is based on the latest evidence and expert opinion at the time of recording. The information is for general purposes only and we cannot offer advice for specific patients. Equally, this information is geared towards healthcare professionals. Any member of the public or patients listening should not use this as advice to treat their own condition or others and should consult their own physician for any medical needs they may have.
In this episode our host Dr Sarah Drummond speaks with Professor Catherine Smith and Dr Andrew Pink about eczema therapeutics:
• Where conventional systemic agents fit within the evolving landscape of eczema therapeutics.
• The biologic agents licensed for use in eczema including their mechanism of action, monitoring requirements and potential side effects.
Recorded: 19 March 2024
For more information, visit: www.stjohnsdermacademy.com/podcasts
Disclaimer: The information on our podcasts is based on the latest evidence and expert opinion at the time of recording. The information is for general purposes only and we cannot offer advice for specific patients. Equally, this information is geared towards healthcare professionals. Any member of the public or patients listening should not use this as advice to treat their own condition or others and should consult their own physician for any medical needs they may have.
In this episode our host Dr Sarah Drummond speaks with Dr Thomas Tull about bullous pemphigoid:
• The clinical features and risk factors for developing bullous pemphigoid
• How to differentiate bullous pemphigoid from other subepidermal blistering disorders
• Management of bullous pemphigoid including:
o Preferred first and second line agents
o How and when to reduce treatment
o What to do in severe and refractory cases
Resources and further reading:
• European guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology, 2022 (updated) (https://onlinelibrary.wiley.com/doi/full/10.1111/jdv.18220)
• British Association of Dermatologists’ guidelines for the management of bullous pemphigoid, 2012 (https://onlinelibrary.wiley.com/doi/full/10.1111/bjd.12072)
Disclosure:
Dr. Tull provides consultancy services for Argenx who market Efgartigimod, which has been referenced in Part 1 and 2 of this series.
Recorded date: 26 January 2024
Please visit our website https://www.stjohnsdermacademy.com/podcasts for episode notes and references.
In this episode our host Dr Sarah Drummond speaks with Dr Thomas Tull about pemphigus vulgaris:
• The clinical features of pemphigus vulgaris and other variants of pemphigus.
• The step-wise management of pemphigus vulgaris including an approach to managing severe disease and the use of rituximab and intravenous immunoglobulin .
Resources and further reading:
• British Association of Dermatologists’ guidelines for the management of pemphigus vulgaris, 2017 (https://onlinelibrary.wiley.com/doi/full/10.1111/bjd.15930)
• European guidelines for the management of pemphigus vulgaris and foliaceous initiated by the European Academy of Dermatology and Venereology, 2020 (https://onlinelibrary.wiley.com/doi/full/10.1111/jdv.16752)
• Rituximab and Covid-19 Risk – a single-centre cohort study (https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(23)00004-8/fulltext)
• Phase 2 Study of efficacy and safety of Rilzabrutinib for patients with pemphigus vulgaris (https://pubmed.ncbi.nlm.nih.gov/35686647/)
• Phase 2 Study of the use of Efgartigimod for patients with pemphigus vulgaris and foliaceous (https://pubmed.ncbi.nlm.nih.gov/34608631/)
Disclosure: Dr. Tull provides consultancy services for Argenx who market Efgartigimod, which has been referenced in Part 1 and 2 of this series.
Recorded date: 26 January 2024
In this episode our host Dr Justin Bui speaks to Dr Fiona Lewis about vulval skin conditions.
In this episode we discuss…
· Management of lichen sclerosus, including what to do when topical steroids are not effective
· Management of vulval eczema and psoriasis
· When to refer to a tertiary service
Please visit our website https://www.stjohnsdermacademy.com/podcasts for episode notes and references.
In this episode our host Dr Justin Bui speaks to Dr Fiona Lewis about vulval skin conditions.
In this episode we discuss…
· Common presentations of vulval skin conditions
· Diagnostic clues in the history
· Clinical examination
· When to consider further investigations including a biopsy
Please visit our website https://www.stjohnsdermacademy.com/podcasts for episode notes and references.
In this episode our host Dr Justin Bui speaks to Dr John Ferguson about vitiligo.
We discuss…
- What is vitiligo?
- The changing perception of vitiligo as a skin disease
- An approach to examining patients with vitiligo
- Other conditions associated with vitiligo
Please visit our website https://www.stjohnsdermacademy.com/podcasts for episode notes and references.
In this episode our host Dr Alison Sears speaks to Dr Susannah Baron and Dr Rukshana Ali about paediatric psychodermatology.
We discuss…
· Compulsive hair pulling (trichotillomania)
· Medically unexplained skin signs
· Psychological tools/exercises
· Practical top tips
Please visit our website https://www.stjohnsdermacademy.com/podcasts for episode notes and references.
In this episode our host Dr Alison Sears speaks to Dr Susannah Baron and Dr Rukshana Ali about paediatric psychodermatology.
We discuss…
· What is psychodermatology?
· Ways of establishing rapport and communicating effectively with children/young people and their families.
· History taking in paediatric psychodermatology
· The importance of communication with parents around acceptance of a child as they are, if they have a skin condition which has a visible difference.
Please visit our website https://www.stjohnsdermacademy.com/podcasts for episode notes and references.
In this episode we discuss…
The indications, benefits and pitfalls of the following treatments for acne scaring:
· Surgical procedures including subcision and punch excision
· Procedures such as microneedling, chemical peels and soft tissue augmentation
· Ablative and non-ablative lasers
Please visit our website https://www.stjohnsdermacademy.com/podcasts for episode notes and references.
In this episode we discuss…
· What causes acne scarring
· When to treat
· How to assess patients
· Different types of atrophic acne scars
Visit our website https://www.stjohnsdermacademy.com/podcasts for show notes and references.
In this episode we discuss:
· Screening questions and investigations to assess for the presence of systemic disease
· Treatment of cutaneous sarcoidosis
· Assessing disease response and monitoring
In this episode we discuss:
· Definition, aetiology and epidemiology of cutaneous sarcoidosis
· Clinical features that characterise cutaneous sarcoidosis
· Diagnosis of cutaneous sarcoidosis
In this episode our host Dr Ally Paolino speaks to Dr Felicity Ferguson about the common types of skin problems in health care workers as a result of heightened personal protective equipment and strategies to prevent and treat these occupational dermatoses.
In this episode Dr Rachael Morris-Jones talks to our host, Dr Ally Paolino about SARS-CoV-2, the typical symptoms and phases of the viral illness, the cutaneous manifestations and their association with disease severity.
In this episode Dr Emma Craythorne talks to our host, Dr Ally Paolino about facial hyperpigmentation, the common causes, treating melasma (including topical, laser and tranexamic acid treatments) and post inflammatory hyperpigmentation.